TCIM
LJPC

TIAA CREF Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

TIAA CREF Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$271K Hold
42,197
– – ﹤0.01% 2812
2018
Q4 		$398K Sell
42,197
-411
-1% -$6.18K ﹤0.01% 2664
2018
Q3 		$858K Sell
42,608
-2,278
-5% -$59.5K ﹤0.01% 2496
2018
Q2 		$1.31M Buy
44,886
+4,060
+10% +$125K ﹤0.01% 2387
2018
Q1 		$1.22M Sell
40,826
-1,632
-4% -$52.6K ﹤0.01% 2337
2017
Q4 		$1.37M Sell
42,458
-3,605
-8% -$118K ﹤0.01% 2315
2017
Q3 		$1.6M Sell
46,063
-980
-2% -$31.5K ﹤0.01% 2289
2017
Q2 		$1.4M Buy
47,043
+10,703
+29% +$307K ﹤0.01% 2381
2017
Q1 		$1.08M Sell
36,340
-2,516
-6% -$64.2K ﹤0.01% 2474
2016
Q4 		$681K Sell
38,856
-3,987
-9% -$76.4K ﹤0.01% 2714
2016
Q3 		$1.02K Sell
42,843
-210
-0.5% -$3.96K ﹤0.01% 2536
2016
Q2 		$689K Buy
43,053
+1,483
+4% +$26.6K ﹤0.01% 2713
2016
Q1 		$869K Hold
41,570
– – ﹤0.01% 2547
2015
Q4 		$1.12M Buy
41,570
+2,169
+6% +$59.1K ﹤0.01% 2511
2015
Q3 		$1.09M Buy
39,401
+20,573
+109% +$648K ﹤0.01% 2524
2015
Q2 		$461K Buy
+18,828
New +$388K ﹤0.01% 2987

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TIAA CREF Investment Management's LJPC Position: Q1 2019 in Review

TIAA CREF Investment Management held its La Jolla Pharmaceutical Company (LJPC) position steady in Q1 2019 at 42,197 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2812.

TIAA CREF Investment Management first reported a position in LJPC in Q2 2015 and has held it in 16 quarters since. The position peaked at $1.6M in Q3 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • TIAA CREF Investment Management held 42,197 shares of La Jolla Pharmaceutical Company worth $271K as of Q1 2019.
  • TIAA CREF Investment Management left its La Jolla Pharmaceutical Company share count unchanged in Q1 2019.
  • La Jolla Pharmaceutical Company made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2812 holding.
  • TIAA CREF Investment Management first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and has held it in 16 quarters since.
  • TIAA CREF Investment Management's La Jolla Pharmaceutical Company position peaked at $1.6M in Q3 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.